Have a personal or library account? Click to login
Structural and biomechanical analysis of femurs from mice treated with diclofenac, miR-15b and miR-365 Cover

References

  1. Glowacki M., Ignys-O’Byrne A., Ignys I. et al., Limb shortening in the course of solitary bone cyst treatment – a comparative study, Skeletal. Radiol., 2011, 40, 173–179.
  2. García-Martínez O., De Luna-Bertos E., Ramos- -Torrecillas J. et al., Repercussions of NSAIDS drugs on bone tissue: the osteoblast, Life Sci., 2015, 123, 72–77.
  3. Krischak G.D., Augat P., Blakytny R. et al., The non-steroidal anti-inflammatory drug diclofenac reduces appearance of osteoblasts in bone defect healing in rats, Arch. Orthop. Trauma Surg., 2007, 127, 453–458.
  4. Lee W.Y., Li N., Lin S. et al., miRNA-29b improves bone healing in mouse fracture model, Mol. Cell. Endocrinol., 2016, 430, 97–107.
  5. Guo S., Zhang M., Huang Y., Three ‘E’ challenges for siRNA drug development, Trends Mol. Med., 2024, 30, 13–24.
  6. Bai Y., Gong X., Dong R. et al., Long non-coding RNA HCAR promotes endochondral bone repair by upregulating VEGF and MMP13 in hypertrophic chondrocyte through sponging miR-15b-5p, Genes. Dis., 2022, 9, 456–465.
  7. Fang S.-H., Chen L., Chen H.-H. et al., MiR-15b ameliorates SONFH by targeting Smad7 and inhibiting osteogenic differentiation of BMSCs, Eur. Rev. Med. Pharmacol. Sci., 2019, 23, 9761–9771.
  8. Vimalraj S., Partridge N.C., Selvamurugan N., A positive role of microRNA-15b on regulation of osteoblast differentiation, J. Cell. Physiol., 2014, 229, 1236–1244.
  9. Franceschetti T., Dole N.S., Kessler C.B. et al., Pathway analysis of microRNA expression profile during murine osteoclastogenesis, PLoS One, 2014, 9, e107262.
  10. Smith S.S., Kessler C.B., Shenoy V. et al., IGF-I 3’ untranslated region: strain-specific polymorphisms and motifs regulating IGF-I in osteoblasts, Endocrinology, 2013, 154, 253–262.
  11. Xu D., Gao Y., Hu N. et al., miR-365 Ameliorates Dexamethasone- Induced Suppression of Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4, Int. J. Mol. Sci., 18. Epub ahead of print 4 May 2017, DOI: 10.3390/ijms18050977.
  12. Chen J., Wu X., Cyclic tensile strain promotes chondrogenesis of bone marrow-derived mesenchymal stem cells by increasing miR-365 expression, Life Sci., 2019, 232, 116625.
  13. Hou C., Zhang Y., Lv Z. et al., Macrophage exosomes modified by miR-365-2-5p promoted osteoblast osteogenic differentiation by targeting OLFML1, Regen. Biomater., 2024, 11, rbae018.
  14. Murakami K., Kikugawa S., Kobayashi Y. et al., Olfactomedin- like protein OLFML1 inhibits Hippo signaling and mineralization in osteoblasts, Biochem. Biophys. Res. Commun., 2018, 505, 419–425.
  15. Hu N., Gao Y., Jayasuriya C.T. et al., Chondrogenic induction of human osteoarthritic cartilage-derived mesenchymal stem cells activates mineralization and hypertrophic and osteogenic gene expression through a mechanomiR, Arthritis Res. Ther., 2019, 21, 167.
  16. Lehmann T.P., Wojtków M., Pruszyńska-Oszmałek E. et al., Trabecular bone remodelling in the femur of C57BL/6J mice treated with diclofenac in combination with treadmill exercise, Acta Bioeng. Biomech., 2021, 23, 3–11.
  17. Leciejewska N., Pruszyńska-Oszmałek E., Mielnik K. et al., Spexin Promotes the Proliferation and Differentiation of C2C12 Cells In Vitro-The Effect of Exercise on SPX and SPX Receptor Expression in Skeletal Muscle In Vivo, Genes (Basel), 13. Epub ahead of print 28 December 2021, DOI: 10.3390/genes13010081.
  18. Lehmann T.P., Iwańczyk-Skalska E., Harasymczuk J. et al., Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and Methylprednisolone, Genes (Basel), 14. Epub ahead of print 10 January 2023, DOI: 10.3390/genes14010184.
  19. Höbel S., Aigner A., Polyethylenimines for siRNA and miRNA delivery in vivo, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2013, 5, 484–501.
  20. Guan Y.-J., Yang X., Wei L. et al., MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4, FASEB J., 2011, 25, 4457–4466.
  21. Ko J.Y., Chuang P.C., Ke H.J. et al., MicroRNA-29a mitigates glucocorticoid induction of bone loss and fatty marrow by rescuing Runx2 acetylation, Bone, 2015, 81, 80–88.
  22. Suttamanatwong S., MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis, Connect. Tissue Res., 2017, 58, 90–102.
  23. Li Y., Wang J., Ma Y. et al., MicroRNA-15b shuttled by bone marrow mesenchymal stem cell-derived extracellular vesicles binds to WWP1 and promotes osteogenic differentiation, Arthritis Res. Ther., 2020, 22, 269.
  24. Vimalraj S., Selvamurugan N., Regulation of proliferation and apoptosis in human osteoblastic cells by microRNA-15b, Int. J. Biol. Macromol., 2015, 79, 490–497.
  25. Shen R., Chen M., Wang Y.-J. et al., Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation, J. Biol. Chem., 2006, 281, 3569–3576.
  26. Sharma A.R., Lee Y.-H., Lee S.-S., Recent advancements of miRNAs in the treatment of bone diseases and their delivery potential, Current Research in Pharmacology and Drug Discovery, 2023, 4, 100150.
  27. Mori M.A., Ludwig R.G., Garcia-Martin R. et al., Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease, Cell. Metab., 2019, 30, 656–673.
  28. Xie X., Cheng P., Hu L. et al., Bone-targeting engineered small extracellular vesicles carrying anti-miR-6359-CGGGAGC prevent valproic acid-induced bone loss, Signal Transduct. Target Ther., 2024, 9, 24.
  29. Lehmann T.P., Golik M., Olejnik J. et al., Potential applications of using tissue-specific EVs in targeted therapy and vaccinology, Biomed. Pharmacother. 2023, 166, 115308.
  30. Zhang Q., Liu Y., Yuan Y. et al., miR-26a-5p protects against drug-induced liver injury via targeting bid, Toxicol. Mech. Methods, 2022, 32, 325–332.
DOI: https://doi.org/10.37190/abb/207864 | Journal eISSN: 2450-6303 | Journal ISSN: 1509-409X
Language: English
Page range: 199 - 209
Submitted on: Mar 22, 2025
Accepted on: Jul 3, 2025
Published on: Aug 26, 2025
Published by: Wroclaw University of Science and Technology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Tomasz P. Lehmann, Aleksandra Trzaskowska, Ewa Pruszyńska-Oszmałek, Paweł Kołodziejski, Magdalena Wojtków, Celina Pezowicz, Sławomir Mielcarek, Agnieszka Hertel, Paweł P. Jagodziński, Maciej Głowacki, published by Wroclaw University of Science and Technology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.